Decoding Tumor Metabolic Dysregulation Through Single‐Cell Analysis Informs the Inverse Design of Therapeutic Nanozymes
Advanced Materials · 13.11.2026
DOI: 10.1002/adma.75692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 13.11.2026. Verfasst von Yimeng Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Materials Science and Engineering, Qingdao University of Science and Technology, Qingdao, Shandong, China. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholar Talent Program, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Single‐node interventions often fail against tumor metabolic networks due to dynamic compensation and pathway redundancy, necessitating synergistic, multi‐node strategies. However, translating high‐dimensional single‐cell omics into physicochemical parameters for materials design remains a major challenge. Herein, a cross‐scale inverse design paradigm for therapeutic nanozymes is proposed that maps single‐cell metabolic demands onto quantum‐chemical descriptors. Using hepatocellular carcinoma (HCC) as a model, integrated single‐cell transcriptomic and metabolic flux analyses revealed a triple vulnerability network involving lactate accumulation, focal hypoxia, and oxidative stress imbalance. Guided by first‐principles calculations and multiparameter screening based on reaction energy barriers and Bader charge transfer, 260 candidate materials were evaluated. This screening identified a nitrogen–phosphorus dual‐coordinated gold single‐atom nanozyme (APNC) with exceptional lactate oxidase (LOX)‐, catalase (CAT)‐, and peroxidase (POD)‐like activities and strong piezoelectric polarization. In vitro and in vivo studies demonstrated that APNC remodels the HCC microenvironment by depleting lactate and alleviating hypoxia, thereby disrupting glycolysis and triggering immunogenic cell death (ICD). APNC‐mediated piezocatalytic therapy achieved 95% tumor inhibition in vivo. This inverse design strategy bridges single‐cell metabolic profiling and atomic‐scale material engineering, establishing a versatile framework for precision nanozyme development across tumors and metabolic disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Materials Science and Engineering, Qingdao University of Science and Technology, Qingdao, Shandong, China.
- Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer, Shanghai Municipal Health Commission, Minhang Hospital, Fudan University, Shanghai, China.
- Department of Laboratory Medicine, Huashan Hospital Fudan University, Shanghai, China.
- Nanchang Medical College, Nanchang, Jiangxi, China.
ORCID-Profile: Weiwei Gao, Qiongzhu Dong, Zhiling Zhu
Förderung
- National Natural Science Foundation of China
- Taishan Scholar Talent Program
- National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Key Discipline Construction of the Shanghai Municipal Health System
Zitieren
APA
Wang, Y., Lin, H., Gao, W., Gao, Y., Lin, H., Zeng, L., Wu, J., Zhang, L., Wang, S., Wang, L., Dong, Q., & Zhu, Z. (2026). Decoding Tumor Metabolic Dysregulation Through Single‐Cell Analysis Informs the Inverse Design of Therapeutic Nanozymes. Advanced Materials. https://doi.org/10.1002/adma.75692
Vancouver
Wang Y, Lin H, Gao W, Gao Y, Lin H, Zeng L, et al. Decoding Tumor Metabolic Dysregulation Through Single‐Cell Analysis Informs the Inverse Design of Therapeutic Nanozymes. Advanced Materials. 2026. doi:10.1002/adma.75692
BibTeX
@article{Wang2026,
author = {Wang, Yimeng and Lin, Hanchao and Gao, Weiwei and Gao, Yonghui and Lin, Hongyu and Zeng, Linzi and Wu, Jiajun and Zhang, Luming and Wang, Sifeng and Wang, Lina and Dong, Qiongzhu and Zhu, Zhiling},
title = {Decoding Tumor Metabolic Dysregulation Through Single‐Cell Analysis Informs the Inverse Design of Therapeutic Nanozymes},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.75692}
}
EUVIMED